10x Genomics, Inc. financial data

Symbol
TXG on Nasdaq
Location
6230 Stoneridge Mall Road, Pleasanton, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 511 % +2.44%
Quick Ratio 59.5 % -17.8%
Debt-to-equity 28.7 % -1.71%
Return On Equity -10.3 % +59.2%
Return On Assets -7.97 % +59%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 122M shares +2.68%
Entity Public Float 1.8B USD -68.4%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 126M shares +3.95%
Weighted Average Number of Shares Outstanding, Diluted 126M shares +3.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 642M USD +1.92%
Cost of Revenue 200M USD -4.95%
Operating Income (Loss) -91.3M USD +54.3%
Nonoperating Income (Expense) 18.2M USD -24.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -73.1M USD +58.5%
Income Tax Expense (Benefit) 3.23M USD -51.4%
Net Income (Loss) Attributable to Parent -76.3M USD +58.2%
Earnings Per Share, Basic 0 USD/shares +59.7%
Earnings Per Share, Diluted 0 USD/shares +59.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 344M USD -4.24%
Accounts Receivable, after Allowance for Credit Loss, Current 43.8M USD -47.6%
Inventory, Net 62M USD -34.1%
Assets, Current 660M USD +11.1%
Property, Plant and Equipment, Net 233M USD -10.1%
Operating Lease, Right-of-Use Asset 63.7M USD +6.83%
Intangible Assets, Net (Excluding Goodwill) 64.8M USD +301%
Goodwill 4.51M USD 0%
Other Assets, Noncurrent 1.88M USD -61.7%
Assets 1.03B USD +9.55%
Accounts Payable, Current 18.1M USD -31.1%
Employee-related Liabilities, Current 37.1M USD +23.3%
Contract with Customer, Liability, Current 22.1M USD +24.7%
Liabilities, Current 147M USD +21.5%
Contract with Customer, Liability, Noncurrent 10.9M USD -12%
Operating Lease, Liability, Noncurrent 76.4M USD -0.03%
Other Liabilities, Noncurrent 6.39M USD +29.3%
Liabilities 242M USD +12.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 138K USD +331%
Retained Earnings (Accumulated Deficit) -1.49B USD -5.38%
Stockholders' Equity Attributable to Parent 785M USD +8.62%
Liabilities and Equity 1.03B USD +9.55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 34.4M USD
Net Cash Provided by (Used in) Financing Activities 422K USD -74.2%
Net Cash Provided by (Used in) Investing Activities -1.89M USD -118%
Common Stock, Shares Authorized 1.1B shares 0%
Common Stock, Shares, Issued 122M shares +2.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 33M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 433M USD +8.68%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 479M USD +8.21%
Deferred Tax Assets, Gross 496M USD +7.76%
Operating Lease, Liability 87M USD +1.29%
Payments to Acquire Property, Plant, and Equipment 1.89M USD -34.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -76.2M USD +58.1%
Lessee, Operating Lease, Liability, to be Paid 107M USD +1.04%
Property, Plant and Equipment, Gross 378M USD -1.32%
Operating Lease, Liability, Current 10.5M USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.8M USD +8.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.6M USD +11.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.9M USD -0.05%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.4M USD +4.39%
Deferred Tax Assets, Operating Loss Carryforwards 162M USD -2.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 50M USD +9.43%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.8M USD -6.72%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.02M USD -12.7%
Deferred Tax Assets, Net of Valuation Allowance 16.7M USD -3.79%
Share-based Payment Arrangement, Expense 116M USD -21.5%
Interest Expense 15K USD -95.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%